| 标题 |
Neoadjuvant treatment with trastuzumab and pertuzumab plus palbociclib and fulvestrant in HER2-positive, ER-positive breast cancer (NA-PHER2): an exploratory, open-label, phase 2 study |
| 网址 | |
| DOI | |
| 其它 |
期刊:Lancet Oncology 作者:Luca Gianni; Giancarlo Bisagni; Marco Colleoni; Lucia Del Mastro; Claudio Zamagni; et al 出版日期:2018-01-08 |
| 求助人 | |
| 下载 | 求助已完成,仅限求助人下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)